Metraipolis › archive › dc_a3d486d8a6a6

Posttransplant cyclophosphamide versus antithymocyte globulin in patients with cardiovascular comorbidity undergoing allogeneic hematopoietic cell… — Europe PMC PMID:41339490

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41339490
DOI
10.1038/s41409-[numero omesso]-0
License (as archived)
solo-consultazione
Archived
2026-11-07T23:52:32.774Z
SHA-256 of the archived text
d18c952354da3d5ebb441014cf957c0a13d9373a2ff6d17a300105832427fff8
Stable URL of this page
https://metraipolis.com/documento/dc_a3d486d8a6a6

How to cite

Posttransplant cyclophosphamide versus antithymocyte globulin in patients with cardiovascular comorbidity undergoing allogeneic hematopoietic cell… — Europe PMC PMID:41339490 — Europe PMC (en), https://europepmc.org/article/MED/41339490 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a3d486d8a6a6 (Metraipolis archive dc_a3d486d8a6a6, sha256 d18c952354da3d5ebb441014cf957c0a13d9373a2ff6d17a300105832427fff8)
BibTeX
@misc{dca3d486d8a6a6,
  title = {Posttransplant cyclophosphamide versus antithymocyte globulin in patients with cardiovascular comorbidity undergoing allogeneic hematopoietic cell… — Europe PMC PMID:41339490},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41339490},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a3d486d8a6a6; sha256 d18c952354da3d5ebb441014cf957c0a13d9373a2ff6d17a300105832427fff8},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41339490. Agents can read the archived copy with the MCP tool read_document.